Medication info
Nebiolet Tablet (Nebivolol Hydrochloride)

Nebiolet Tablet (Nebivolol Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Nebivolol Hydrochloride›5.45mg / 1 tablet
Manufacturer / importer
Youngjin Pharmaceutical Co., Ltd.
Appearance
White round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201104062 · Approved 2011.06.30 · Insurance code 642403270

Summary

Main use
Treatment of essential hypertension; adjunctive treatment of chronic heart failure in patients aged 70 years or older
Who takes it
Adults
Adult dose
1. Essential hypertension (1) Adults Administer 5mg of nebivolol orally once daily at the same time each day. The blood pressure-lowering effect usually appears after 1~2 weeks of treatment, although it may appear after 4 weeks in some cases. May be taken with food. (2) Patients with renal impairment The initial dose is 2.5mg of nebivolol orally once daily. If necessary, the daily dose may be increased to 5mg. (3) Older adults The initial dose for older adults aged 65 years and older is 2.5mg of nebivolol once daily. If necessary, the daily dose may be increased to 5mg. Since clinical experience in patients aged 75 years and older is insufficient, administer with careful monitoring. 2. Chronic heart failure (1) Older patients aged 70 years and older This medicine should be administered to patients with chronic stable heart failure who have had no history of acute heart failure in the past 6 weeks. Doses of cardiovascular medicines such as diuretics, digoxin, ACE inhibitors, and angiotensin II receptor blockers should have been stabilized by 2 weeks before starting this medicine. Considering the patient's condition, the dose should be gradually increased at intervals of 1~2 weeks until the optimal dose for each patient is reached. Start treatment with 1.25mg of nebivolol once daily and, if necessary, the dose may be increased to 2.5 mg once daily, 5 mg once daily, and up to 10 mg once daily. The maximum daily dose is 10 mg. May be taken with food. (2) Patients with renal impairment Since titration to the maximum tolerated dose is adjusted for each patient, no dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment (serum creatinine ≥ 250 μ mol/L), as there is no experience with use in these patients.

Ingredients

Manufacturer
Youngjin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; adjunctive treatment of chronic heart failure in patients aged 70 years or older

  • Essential hypertension
  • chronic heart failure
View approved original text

This medication is used to treat essential hypertension and helps lower blood pressure to prevent cardiovascular diseases. It is also used as an adjunctive treatment for the standard care of elderly patients over 70 years with mild to moderate chronic stable heart failure, aiding in the improvement of heart failure symptoms. Therefore, it is effective in treating hypertension and chronic heart failure in the elderly.

How to take

Adult dose

1. Essential hypertension (1) Adults Administer 5mg of nebivolol orally once daily at the same time each day. The blood pressure-lowering effect usually appears after 1~2 weeks of treatment, although it may appear after 4 weeks in some cases. May be taken with food. (2) Patients with renal impairment The initial dose is 2.5mg of nebivolol orally once daily. If necessary, the daily dose may be increased to 5mg. (3) Older adults The initial dose for older adults aged 65 years and older is 2.5mg of nebivolol once daily. If necessary, the daily dose may be increased to 5mg. Since clinical experience in patients aged 75 years and older is insufficient, administer with careful monitoring. 2. Chronic heart failure (1) Older patients aged 70 years and older This medicine should be administered to patients with chronic stable heart failure who have had no history of acute heart failure in the past 6 weeks. Doses of cardiovascular medicines such as diuretics, digoxin, ACE inhibitors, and angiotensin II receptor blockers should have been stabilized by 2 weeks before starting this medicine. Considering the patient's condition, the dose should be gradually increased at intervals of 1~2 weeks until the optimal dose for each patient is reached. Start treatment with 1.25mg of nebivolol once daily and, if necessary, the dose may be increased to 2.5 mg once daily, 5 mg once daily, and up to 10 mg once daily. The maximum daily dose is 10 mg. May be taken with food. (2) Patients with renal impairment Since titration to the maximum tolerated dose is adjusted for each patient, no dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment (serum creatinine ≥ 250 μ mol/L), as there is no experience with use in these patients.

Precautions

This medication should not be used in patients with certain conditions or diseases. For example, patients who are allergic to this medication, or have bronchospasm, bronchial asthma, severe heart failure, bradycardia, hypotension, severe peripheral circulation disorders, or severely impaired liver or kidney function may face risks taking this medication. Additionally, pregnant or breastfeeding women are advised against using this medication. This drug contains lactose, so patients with lactose intolerance should not take it. Caution is required when administering this medication to patients with chronic lung disease, untreated heart failure, atrioventricular block, diabetes, and the elderly, and it is important to consult a physician before taking it. Side effects such as skin rash, visual impairment, bradycardia, hypotension, headache, dizziness, dyspepsia, breathlessness, edema, and fatigue may occur with this medication. Rarely, psychiatric symptoms, bronchospasm, or exacerbation of psoriasis may occur. Particularly for heart failure patients, careful monitoring is necessary as symptoms may worsen during treatment with this medication. It is essential to regularly check blood pressure and heart rate after taking the medication. This medication may interact with other drugs, so follow medical advice when taking it with calcium channel blockers, antiarrhythmics, central acting antihypertensives, insulin, and anticonvulsants. It is safest for pregnant or breastfeeding women to avoid this medication, and it is recommended not to use it in children as safety and efficacy have not been established. The elderly should start at a low dose and be administered cautiously to avoid excessive blood pressure reduction. In the case of overdose, bradycardia, hypotension, bronchospasm, and heart failure symptoms may occur, so immediate medical assistance is necessary for proper treatment.

Side effects

Rash, vision impairment, bradycardia, AV block, AV conduction delay, hypotension, heart failure, intermittent claudication, headache, dizziness, paresthesia, depression, nightmares, syncope, diarrhea, constipation, nausea, indigestion, bloating, vomiting, dyspnea, bronchospasm, pruritus, erythematous rash, exacerbation of psoriasis, edema, fatigue, erectile dysfunction, vascular nondescript edema, hallucinations, psychosis, confusion, cyanosis of limbs, dry eyes, practolol-type conjunctival skin toxicity, Raynaud's phenomenon, orthostatic hypotension, drug intolerance, lower limb edema, insomnia, palpitations, abdominal pain, frequent urination, increased blood glucose, neck/shoulder pain, gastritis, chest pain, weakness, lack of efficacy, weight loss, cough, cold, dry cough, loss of appetite, anxiety, back pain, increased serum creatinine, tinnitus, dizziness, tremors, neuromuscular disease, gastroesophageal reflux, irritable bowel syndrome, thirst, gastric ulcer, gastrointestinal disturbance, general weakness, facial edema, generalized edema, upper respiratory tract infection, rhinitis, sore throat, runny nose, restlessness, drowsiness, joint pain, flank pain, neck stiffness, lower back pain, increased BUN, bladder discomfort, cystitis, urinary stones, hematuria, diabetes, urticaria, athletes foot, sweating, tinea, hypertension, cerebrovascular disease, peripheral vascular disease, flushing, nosebleed, increased ALT, increased AST, viral infection, thyroiditis, chronic myelogenous leukemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, avoid very hot or very cold places, and it is advisable to store it at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.